Douglas S. Hawkins, MD
Dr. Hawkins treats pediatric and young adult oncology patients, with a special interest in Ewing's sarcoma, rhabdomyosarcoma, and osteosarcoma.Patient Care Philosophy:
I enjoy working with patients and families to develop the best treatment approach, balancing optimal chance for cure with short-term and long-term side effects. The environment of the SCCA fosters close collaboration between the members of the medical care team with patients and families. An important part of my role is to bring all of the parts of the care team together into a unified plan of treatment.
Title
- Associate Division Chief, Hematology/Oncology, Seattle Children's
- Professor of Pediatrics, University of Washington School of Medicine
Clinical Expertise
Pediatric Hematology Oncology, Ewing's and Rhabdomyosarcoma, Osteosarcoma
Education And Training
- Harvard Medical School, 1990
- Residency: University of Washington, 1990-1993
- Fellowship: Fred Hutchinson Cancer Research Center, 1993-1996
More Information
- Dr. Hawkins was recognized as a 2012 "Top Doctor" in Seattle Magazine's 2012 annual survey.
Clinical Trials
Dr. Hawkins is the SCCA lead investigator for the following clinical trials:
- Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma (COG ARST0332)
- Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor (COG ARAR0332)